Skip to Main Content

Paper Details

Safety of sodium-glucose co-transporter-2 inhibitors on amputation across categories of baseline cardiovascular disease and diuretics use in patients with type 2 diabetes.
Diabetes Obes Metab
1
2023
CVD, DPP4is, DU, SGLT2is, amputation, cardiovascular disease, dipeptidyl peptidase-4, glucose, patient, patients, sodium, sodium-, sodium-glucose co-transporter-2, type 2 diabetes
Author NameAffiliation
Young Min ChoDepartment of Internal Medicine Seoul National University College of Medicine
Young Min ChoInstitute on Aging, Seoul National University
Young Min ChoSeoul National University Hospital
Young Min ChoSeoul National University College of Medicine
Seng Chan YouYonsei University College of Medicine
Seng Chan YouYonsei University College of Medicine
  • 1 - 6

Datasets

Release 1.2